Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Retatrutide (Lilly's triple agonist targeting GLP-1, GIP, and glucagon receptors) is showing unprecedented effectiveness plus significant non-scale benefits, including fatty liver reduction but is still years from approval
Its important to note that not everyone will experience these side effects, and they often diminish over time
The two biggest reasons were that the medication wasnt available at their pharmacy and that many patients didnt have coverage and couldnt afford the $1,000-or-more price tag
LillyDirect offers Zepbound vials at $299-449/month for self-pay patients
US$ 27.69
US$ 20.56
US$ 29.41
US$ 22.01
US$ 28.28
US$ 21.95
